v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net Income (Loss) $ (3,194,080) $ (1,768,415)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 52,746 47,483
Stock-based compensation expense 419,245 352,833
Non-cash operating lease expense 1,172 8,650
Common stock issued in exchange for services 250,000
Net gain from change in fair value of derivative liability instrument (2,574,971)
Gain from change in fair value of forward contract liability (380,442)
Amortization of deferred offering cost 496,948
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 105,025 (204,505)
Accounts payable and accrued expenses 2,261,456 202,649
Net cash used in operating activities (2,562,901) (1,361,305)
Cash flows from investing activities:    
Purchases of intangible assets (152,986) (99,475)
Net cash used in investing activities (152,986) (99,475)
Cash flows from financing activities:    
Proceeds from issuance of stock, net of issuance costs 6,919,432 1,152,382
Net cash provided by financing activities 6,919,432 1,152,382
Net increase (decrease) in cash and cash equivalents 4,203,545 (308,398)
Cash and cash equivalents at beginning of year 872,599 1,180,997
Cash and cash equivalents at end of year 5,076,144 872,599
Supplemental disclosure of non-cash activities    
Right-of-use asset acquired against lease liability 133,615
Common stock issued for deferred offering cost 850,000
Settlement of forward contract liability for sale of shares to GEM pursuant to Initial Draw Down Notice $ 380,442
Issuance of warrant under Share Purchase Agreement for deferred offering costs 5,603,372